APA (7th ed.) Citation

SM, T., BD, P., P, T., JU, F., K, H., S, G., . . . LM, C. (2022). Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2. Pharmaceuticals (Basel, Switzerland), 15(9), . https://doi.org/10.3390/ph15091090

Chicago Style (17th ed.) Citation

SM, Tijono, Palmer BD, Tomek P, Flanagan JU, Henare K, Gamage S, Braun L, and Ching LM. "Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2." Pharmaceuticals (Basel, Switzerland) 15, no. 9 (2022). https://doi.org/10.3390/ph15091090.

MLA (9th ed.) Citation

SM, Tijono, et al. "Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2." Pharmaceuticals (Basel, Switzerland), vol. 15, no. 9, 2022, https://doi.org/10.3390/ph15091090.